Herzog elected president of GOG Foundation board
Thomas Herzog, MD, Class of 1986, deputy director of the UC Cancer Center and professor in the Department of Obstetrics and Gynecology, has been elected president of the GOG Foundation, Inc. (GOG-F) Board of Directors. He will serve as the president-elect for one-year before becoming president in July 2023.
Founded in 1970 as the Gynecologic Oncology Group, the GOG-F is a not-for-profit organization that conducts clinical and translational research on the prevention and treatment of gynecologic malignancies. The GOG-F includes the GOG Foundation, corporate membership in NRG Oncology and the GOG-P program. In addition to the NRG responsibilities, Herzog also will oversee the GOG Partners program. The GOG-F consists of gynecologic oncologists, medical oncologists, pathologists, radiation oncologists, oncology nurses, biostatisticians, basic scientists, quality of life experts, data managers and administrative personnel.
Herzog, who also is the Paul and Carolyn Flory Professor of Gynecologic Oncology, has been a member of the GOG-F Board of Directors, has served as treasurer for the past eight years and is currently an associate director of the GOG Partners program, which collaborates with pharmaceutical organizations to operate clinical trials. He serves or has served on the editorial boards of Gynecologic Oncology, Obstetrics and Gynecology International, and Hematology Oncology Times, among others, and has served as editor-in-chief of Women’s Oncology Review and Gynecologic Oncology Research to Practice. Herzog also has served on the boards or leadership councils of the Society of Gynecologic Oncology, Foundation for Women’s Cancer, American College of Surgeons, American Board of Obstetrics and Gynecology-Gynecologic Oncology Division and the International Gynecologic Cancer Society.
Related Stories
Still the top ‘cat
October 20, 2026
The University of Cincinnati Bearcat mascot was voted Cincinnati’s favorite mascot in a Cincinnati Enquirer reader poll, earning 45.1% of the vote and topping other local favorites.
Researchers test gene therapy as less invasive treatment for hydrocephalus
October 20, 2026
Researchers at the University of Cincinnati College of Medicine say an experimental gene therapy could eventually lead to a less invasive treatment for hydrocephalus, a condition in which excess fluid accumulates in the brain. The early-stage study, led by Agnes (Yu) Luo, PhD, professor and vice chair for research, was published in the journal Fluids and Barriers of the CNS. Yahoo! News recently featured it.
Ultra-processed food intake may increase dementia, stroke risk
October 20, 2026
The University of Cincinnati's Suzanne Judd, PhD, commented to Healthline on a new study that found healthy adults who eat high levels of ultra-processed foods may be more likely to show signs of damage to the brain that could increase the likelihood of stroke and future memory problems.